XML 84 R51.htm IDEA: XBRL DOCUMENT v3.25.0.1
Business Combinations - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Nov. 21, 2024
Jan. 05, 2024
Dec. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Business Acquisition [Line Items]            
Common stock, par value (in dollars per share)     $ 0.001 $ 0.001 $ 0.001  
Acquisition-related transaction cost     $ 27,979   $ 6,485 $ 3,857
SomaLogic Inc.            
Business Acquisition [Line Items]            
Revenue       $ 82,300    
Loss       $ 36,400    
Minimum            
Business Acquisition [Line Items]            
Cumulative discounted cash flow percentage     85.00%      
Maximum            
Business Acquisition [Line Items]            
Cumulative discounted cash flow percentage     90.00%      
Selling, general and administrative expense            
Business Acquisition [Line Items]            
Transaction bonuses incurred     $ 1,900      
Transaction and integration expenses            
Business Acquisition [Line Items]            
Acquisition-related transaction cost     12,300      
Standard BioTools            
Business Acquisition [Line Items]            
Exchanged common stock   $ 1.11        
Amount of common stock   $ 188,808        
Value of consideration transferred   444,219        
Standard BioTools | Common Stock            
Business Acquisition [Line Items]            
Amount of common stock   $ 419,200        
Sengenics            
Business Acquisition [Line Items]            
Exchanged common stock $ 1.62          
Value of consideration transferred $ 13,690          
Acquisition-related transaction cost     $ 1,400      
Revenue $ 10,000          
Acquired of the equity interests 100.00%          
Purchase price, cash $ 2,212          
Consideration transferred shares 3,627,959          
Sengenics | Minimum            
Business Acquisition [Line Items]            
Cumulative discounted cash flow percentage 85.00%          
Sengenics | Maximum            
Business Acquisition [Line Items]            
Cumulative discounted cash flow percentage 90.00%          
Contingent payments $ 21,000